Borealis’ high resistance LE6609-PH BFS re-lanuched

20-Jul-2009 - Last updated on 21-Jul-2009 at 10:36 GMT

Austria’s Borealis has brought its Bormed LE6609-PH BFS grade plastic back to market in a move that, it claims, will allow converters to speed up their production cycles by reducing autoclave residence time.

Bormed LE6609-PH, a low density polythene (LDPE) designed for the production of bottles and ampoules, can be treated using radiation, ethylene oxide (EtO) or at temperatures of up to 110 °C, making it suitable for manufacturing applications were sterility is vital.

The main reasons for this durability, according to Borealis spokesperson Heidi Elsenhuber, are the production processes the firm employs during manufacture that give Bormed LE6609-PH one of the highest densities of any LDPE on the market.

She told in-PharmaTechnologist that the product, which was originally withdrawn after the sale of the firm’s manufacturing facility, is being re-launched in response to “strong demand from customers.”

“Low density polyethylene is one of the most common used in blow fill and seal (BFS) process…as it is flexible, sterilisable and is additive free so can be used for pharmaceutical packaging, including for injectables and IV solutions.”

In a press statement, Borealis said that Bormed LE6609-PH's “optimised molecular weight distribution” and “low swell” characteristics will allow drug packaging firms to reduce wall thickness, material wastage and the weight of individual product packs.

The Viennese firm also believes that the product’s compliance with European and US pharmacopeal regulations and existing drug master file (DMF) registration, will benefit pharmaceutical industry end users.

In a press statement, Borealis’ application marketing manager, Martyna Matelska-Jucha, suggested that the re-launch “puts us at the forefront in offering a product with a unique package of benefits that satisfies converter, brand owner and end-user requirements.”